<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03976986</url>
  </required_header>
  <id_info>
    <org_study_id>cop2016</org_study_id>
    <nct_id>NCT03976986</nct_id>
  </id_info>
  <brief_title>Assessment of Portable Oxygen Concentrators in Infants Undergoing Hypoxic Challenge Testing.</brief_title>
  <official_title>Assessment of Portable Oxygen Concentrators in Infants Undergoing Hypoxic Challenge Testing. A Randomized Crossover Study.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Son Espases</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Son Espases</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Hypoxic Challenge Testing (HCT) is the recommended method for inflight hypoxia risk
      assessment. Onboard oxygen administration remains controversial. The Federal Aviation
      Administration approved portable oxygen concentrators (POCs) for onboard oxygen supply but
      there is lack of evidence about the use, especially in children. The aim of our study is to
      establish the effectiveness and safety of POCs in infants undergoing HCT.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      According to a forecast by International Air Transport Association the number of people
      travelling on commercial aircrafts is predicted to rise up to 8.2 billion passengers in 2037.
      Therefore evidence-based flight recommendations will gain importance in the future,
      especially for patients suffering from chronic diseases. Hypoxic Challenge Testing (HCT) is
      the recommended method for inflight hypoxia risk assessment where nitrogen is introduced in a
      plethysmograph reducing FiO2 (fraction of inspired oxygen) to 0.15. Oxygen supply is
      recommended if PaO2 (partial pressure of oxygen in arterial blood) drops &lt;50-55 mmHg (in
      adults) or Sat.O2 (oxygen saturation) ≤ 85% (in infants) where non-invasive pulse oximetry is
      the recommended method for hypoxia assessment. Onboard oxygen administration remains
      controversial. The effectiveness of pulsed-dosed systems remains unclear in small patients
      due to shallow breathing patterns. The aim of our study is to establish the effectiveness and
      safety of POCs in infants undergoing HCT.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 11, 2016</start_date>
  <completion_date type="Actual">February 4, 2019</completion_date>
  <primary_completion_date type="Actual">February 4, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of portable oxygen concentrators (POCs) to change HCT induced hypoxia (Sat.O2 drop ≤ 85%).</measure>
    <time_frame>20 minutes</time_frame>
    <description>Hypoxia (Sat.O2 drop ≤ 85%) measured by Masimo SET Radical-7 Electron® pulse oximeter is induced performing HCT. Thereafter oxygen is administered through cPOC or pPOC until baseline Sat.O2 (Sat.O2 &gt;93%) is achieved.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>POC comparison to change HCT induced hypoxia (Sat.O2 drop ≤ 85%).</measure>
    <time_frame>20 minutes</time_frame>
    <description>Compare the capacity of different POCs: continuous flow (cPOC) versus pulsed flow (pPOC) to change HCT induced hypoxia (Sat.O2 ≤ 85%) until baseline Sat.O2 (Sat.O2 &gt;93%) is achieved.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relate patient age (months) to POCs capacity to change HCT induced hypoxia (Sat.O2 drop ≤ 85%).</measure>
    <time_frame>20 minutes</time_frame>
    <description>Relationship between patient age (months) and POCs capacity to change hypoxic state (≤ 85%) to baseline Sat.O2 (&gt;93%) measured by Masimo SET Radical-7 Electron®</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Relate patient weight (kilograms) to POCs capacity to change HCT induced hypoxia (Sat.O2 drop ≤ 85%).</measure>
    <time_frame>20 minutes</time_frame>
    <description>Relationship between patient weight (kilograms) and POCs capacity to change hypoxic state (≤ 85%) to baseline Sat.O2 (&gt;93%) measured by Masimo SET Radical-7 Electron®</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">26</enrollment>
  <condition>Hypoxia, Altitude</condition>
  <arm_group>
    <arm_group_label>cPOC - pPOC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Randomized crossover study (according to a random number table): Patients are allocated randomly to two study groups (cPOC/pPOC). In case of Sat.O2 drop ≤ 85% during HCT, oxygen is administered by cPOC (continuous-flow). For patients who show a positive POC hypoxic reversal, HCT is repeated at 24 hours and oxygen is administered by pPOC (pulsed-flow).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pPOC - cPOC</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Randomized crossover study (according to a random number table): Patients are allocated randomly to two study groups (cPOC/pPOC). In case of Sat.O2 drop ≤ 85% during HCT, oxygen is administered by pPOC (pulsed-flow). For patients who show a positive POC hypoxic reversal, HCT is repeated at 24 hours and oxygen is administered by cPOC (continuous-flow).</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>continuous-flow portable oxygen concentrator (cPOC)</intervention_name>
    <description>SeQal Eclipse 3® on continuous-flow (SeQual,Ball Ground,GA): flow rate 2 litre per minute (lpm).</description>
    <arm_group_label>cPOC - pPOC</arm_group_label>
    <arm_group_label>pPOC - cPOC</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>pulsed-flow portable oxygen concentrator (pPOC)</intervention_name>
    <description>InogenOne G3® (Inogen,Goleta,CA) on pulsed-flow mode: setting 2 (flow rate 420 ml/min, 16.8 ml +/- 3ml per bolus at 25 rpm).</description>
    <arm_group_label>cPOC - pPOC</arm_group_label>
    <arm_group_label>pPOC - cPOC</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Patients with baseline Sat.O2 &gt;94% AND

          -  &lt;1 year with neonatal respiratory disease

          -  required oxygen supply in the last 6 months

          -  chronic respiratory disease (eg cystic fibrosis, obstructive or restrictive pulmonary
             disease) with FEV 1 (forced expiratory volume in 1 second) or FVC (forced vital
             capacity) &lt;50%.

        Exclusion Criteria:

          -  acute respiratory infection
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>16 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sebastian Sailer, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Son Espases</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Hospital Son Espases</name>
      <address>
        <city>Palma Mallorca</city>
        <state>Mallorca</state>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <results_reference>
    <citation>Ahmedzai S, Balfour-Lynn IM, Bewick T, Buchdahl R, Coker RK, Cummin AR, Gradwell DP, Howard L, Innes JA, Johnson AO, Lim E, Lim WS, McKinlay KP, Partridge MR, Popplestone M, Pozniak A, Robson A, Shovlin CL, Shrikrishna D, Simonds A, Tait P, Thomas M; British Thoracic Society Standards of Care Committee. Managing passengers with stable respiratory disease planning air travel: British Thoracic Society recommendations. Thorax. 2011 Sep;66 Suppl 1:i1-30. doi: 10.1136/thoraxjnl-2011-200295.</citation>
    <PMID>21856702</PMID>
  </results_reference>
  <results_reference>
    <citation>Gong H Jr, Tashkin DP, Lee EY, Simmons MS. Hypoxia-altitude simulation test. Evaluation of patients with chronic airway obstruction. Am Rev Respir Dis. 1984 Dec;130(6):980-6.</citation>
    <PMID>6508019</PMID>
  </results_reference>
  <results_reference>
    <citation>Blakeman TC, Rodriquez D Jr, Gerlach TW, Dorlac WC, Johannigman JA, Branson RD. Oxygen requirement to reverse altitude-induced hypoxemia with continuous flow and pulsed dose oxygen. Aerosp Med Hum Perform. 2015 Apr;86(4):351-6. doi: 10.3357/AMHP.4184.2015.</citation>
    <PMID>25945551</PMID>
  </results_reference>
  <results_reference>
    <citation>Fischer R, Wanka ER, Einhaeupl F, Voll K, Schiffl H, Lang SM, Gruss M, Ferrari U. Comparison of portable oxygen concentrators in a simulated airplane environment. Respir Med. 2013 Jan;107(1):147-9. doi: 10.1016/j.rmed.2012.10.001. Epub 2012 Oct 22.</citation>
    <PMID>23085214</PMID>
  </results_reference>
  <results_reference>
    <citation>Bunel V, Shoukri A, Choin F, Roblin S, Smith C, Similowski T, Morélot-Panzini C, Gonzalez J. Bench Evaluation of Four Portable Oxygen Concentrators Under Different Conditions Representing Altitudes of 2438, 4200, and 8000 m. High Alt Med Biol. 2016 Dec;17(4):370-374.</citation>
    <PMID>27959667</PMID>
  </results_reference>
  <results_reference>
    <citation>Chen JZ, Katz IM, Pichelin M, Zhu K, Caillibotte G, Finlay WH, Martin AR. In Vitro-In Silico Comparison of Pulsed Oxygen Delivery From Portable Oxygen Concentrators Versus Continuous Flow Oxygen Delivery. Respir Care. 2019 Feb;64(2):117-129. doi: 10.4187/respcare.06359. Epub 2019 Jan 29.</citation>
    <PMID>30696754</PMID>
  </results_reference>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>May 31, 2019</study_first_submitted>
  <study_first_submitted_qc>June 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2019</study_first_posted>
  <last_update_submitted>June 4, 2019</last_update_submitted>
  <last_update_submitted_qc>June 4, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Son Espases</investigator_affiliation>
    <investigator_full_name>Sebastian Sailer</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Infants</keyword>
  <keyword>Hypoxia Altitude Simulation Test</keyword>
  <keyword>Oxygen Delivery Device</keyword>
  <keyword>Portable Oxygen Concentrator</keyword>
  <keyword>Hypoxic Challenge Testing</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Altitude Sickness</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

